Presentation is loading. Please wait.

Presentation is loading. Please wait.

Critical Care Board Review

Similar presentations


Presentation on theme: "Critical Care Board Review"— Presentation transcript:

1 Critical Care Board Review
Pulmonary and Critical Care

2 Normal Pulmonary Physiology
The upright lung can then be divided into 3 zones: Zone 1: (apex) the pulmonary artery pressure is less than the alveolar pressure and therefore there is essentially no blood flow – PA > Pa > Pv Zone 2: (middle part of the lungs) the pulmonary artery pressure is greater than the alveolar pressure, which in turn is greater than the pulmonary venous pressure. In this zone, the blood flow is due to the difference between pulmonary arterial pressure and alveolar pressure - Pa > PA > Pv Zone 3: (base) the venous pressure exceeds alveolar pressure which results in the distension of capillaries. In this zone, a small increase in venous pressure can cause pulmonary edema - Pa > Pv > PA

3 Normal Pulmonary Physiology
Boundaries between zones are not fixed and depend on physiologic conditions ie. low cardiac output, positive pressure ventilation, proning In normal persons, there is no zone 1 Ideally, PCWP measurements should be done in Zone 3

4 Respiratory Failure Type I Type II Type III
Acute hypoxemic respiratory failure Inability to provide adequate oxygen to the blood and tissues Type II Ventilatory failure Failure of alveolar ventilation leading to a rising CO2 and a falling PaO2 Type III Mixed I and II

5 Type I Results when enough disease causing collapse, alveolar filling, or both occurs leading to an effective shunt Will present with marked dyspnea and tachypnea Can be divided into diffuse and focal diseases

6 Diffuse Lung Lesions (Producing Pulmonary Edema) Focal Lung Lesions
Cardiogenic or increased-pressure edema  Left-ventricular (LV) failure     Acute LV ischemia     Accelerated or malignant hypertension     Mitral regurgitation     Volume overload, particularly with coexisting renal and cardiac disease Increased permeability or low-pressure edema (ARDS) Sepsis and sepsis syndrome         Mitral stenosis  Acid aspiration         Multiple transfusions for hypovolemic shock   Near-drowning         Pancreatitis         Air or fat emboli        Cardiopulmonary bypass         Pneumonia         Drug reaction or overdose           Inhalation injury         Infusion of biologics (e.g., interleukin 2)        Ischemia-reperfusion (e.g., postthrombectomy, posttransplantation) Edema of unclear or "mixed" origin Reexpansion     Neurogenic     Postictal     Tocolysis-associated Diffuse alveolar hemorrhage    Microscopic angiitis     Collagen vascular diseases     Goodpasture's syndrome     Severe coagulopathy and bone marrow transplantation    Retinoic acid syndrome Focal Lung Lesions Lobar pneumonia Lung contusion Lobar atelectasis (acutely

7 Type II 3 underlying causes: Consequences
depressed respiratory drive (CNS) neuromuscular incompetence excessive respiratory work load Consequences Hypoxemia PAO2 = FiO2( ) – PaCO2/RQ Acidemia If HCO3 = 24, then pH decreases .08 for ever rise in CO2 by 10 Effects – depression of cardiac and respiratory muscle contractility, arterial vasodilation, increased cerebral blood flow

8

9 ALI/ARDS 1st American and European Consensus Conference report in 1993 standardized the definition of ALI and ARDS: ALI PaO2/FiO2 < 300 ARDS PaO2/FiO2 < 200 Bilateral chest infiltrates PCWP < 18

10 ALI/ARDS Characterized by diffuse alveolar damage Mortality 35-40%
Inflammatory cytokines and toxic mediators damage capillary-alveolar membranes Disruption normal protective barrier results in alveolar filling with protein rich edema and hyaline membranes Mortality 35-40% Sepsis most common cause

11 ALI/ARDS Causes Increased permeability or low-pressure edema
Sepsis and sepsis syndrome         Mitral stenosis  Acid aspiration         Multiple transfusions for hypovolemic shock   Near-drowning        Pancreatitis         Air or fat emboli        Cardiopulmonary bypass         Pneumonia         Drug reaction or overdose           Inhalation injury         Infusion of biologics (e.g., interleukin 2)        Ischemia-reperfusion (e.g., postthrombectomy, posttransplantation) Edema of unclear or "mixed" origin Reexpansion     Neurogenic     Postictal     Tocolysis-associated

12 ALI/ARDS Treatment consists of supportive care while reversing the underlying cause Most patients require mechanical ventilation to support oxygenation and ventilation Goal of ventilatory support is “lung protective strategies” to prevent barotrauma and alveolar distension Low tidal volume ventilation +/- permissive hyperCO2 Use of PEEP to improve oxygenation and prevent cyclical atelectasis

13 ALI/ARDS Low tidal volume ventilation ARDSnet trial 861 patients
Randomized to TV 6ml/kg ideal body weight and goal plat pressure <30 cmH2O versus 12ml/kg and plat pressure <50 Study stopped early when significant mortality benefit in low TV group (31 vs 40%)

14 ALI/ARDS PEEP Allows adequate oxygenation with lower fractions of inhaled oxygen Improves oxygenation by preventing de-recruitment of alveoli thereby improving V/Q mismatch Optimal PEEP varies from patient to patient and is unknown

15

16 PEEP Side effects Overdistension of more normal areas of lung
Can result in barotrauma Hypotension due to increased intrathoracic pressure and reduced venous return (preload) Elevates ICP? (theoretical)

17 Intrinsic PEEP (auto PEEP)
Patients with COPD often have elevated end expiratory pressure in the alveoli unlike normal patients in whom the end-expiratory pressure is usually zero This elevated end-expiratory pressure is known as intrinsic PEEP or auto PEEP.

18 Intrinsic PEEP Intrinsic PEEP results in:
Decreased cardiac output due to increased intrathoracic pressure Increased work of breathing when the patient initiates a spontaneous breath while on the ventilator the patient has to generate an equal amount of negative pressure to overcome the positive intrinsic (auto) PEEP before pulmonary airflow can be initiated

19 Intrinsic PEEP In patients on ventilator, this intrinsic PEEP may be difficult to recognize unless the expiratory circuit on the ventilator is occluded at the end of expiration When this is done, the pressure in the ventilator circuit and the lungs will equilibrate and hence, the ventilator manometer will display the amount of intrinsic PEEP.

20 Intrinsic PEEP Ways to correct auto PEEP: Prolong the expiratory time
Increase inspiratory flow rate Lower respiratory rate Lower tidal volume Treat the obstruction Bronchodilators Steroids Disconnect from the ventilator

21 Hemodynamic Monitoring
PA catheters provide capability to obtain direct measurements of central venous, right sided cardiac, pulmonary artery, and pulmonary capillary wedge pressure; thermodilution CO; mixed venous saturation Controversial due to lack of any study demonstrating improved clinical outcome Any decision to insert a Swan-Ganz catheter for monitoring must be carefully weighed against the potential risk of complications.

22 Hemodynamic Monitoring
PA catheter indications: Differentiation of shock Determination of cardio- vs. noncardiogenic pulmonary edema Evaluate pulmonary HTN Diagnose tamponade Diagnose intracardiac shunt Periop management of complicated cardiac patients Guide to pressor usage Guide to nonpharmacologic management

23 Hemodynamic Monitoring
PA catheter complications: Trauma to heart or vessels during insertion Dysrhythmias Knotting PA rupture due to “overwedging” Pulmonary infarct Thrombosis Infection

24 Hemodynamic Monitoring
Normal: 0-7 Elevated RA: RV infarct Volume overload Pulmonary HTN R sided valve disease L to R shunts Cannon a’s: AV dissociation Cannon v’s: TR

25 Hemodynamic Monitoring
Normal: over 3-12 Elevated RV pressure: Pulmonary HTN Pulmonary stenosis PE

26 Hemodynamic Monitoring
Normal: over 8-15 Elevated PA pressure: L heart failure Lung disease PE L to R shunts Pulmonary HTN Mitral valve disease Hypoxic vasoconstriction

27 Hemodynamic Monitoring
Normal: 6-12 Always performed at end exhalation Elevated PCWP: Volume overload L heart failure Mitral disease Myocardial ischemia/infarct

28 Hemodynamic Monitoring
Other normals: CO 4-6 L/min CI L/min/m2 SVR dynes/sec/cm2 PVR dynes/sec/cm2 SVO2 >65%

29 Shock

30 Common Signs and Symptoms of Shock
Hypotension Skin changes cool, clammy skin; livedo reticularis Oliguria decreased renal perfusion Altered mental status restlessness>agitation>obtundation>coma Metabolic acidosis poor clearance of lactate by kidney, muscle, liver

31 Classification of Shock
HYPOVOLEMIC CARDIOGENIC DISTRIBUTIVE OBSTRUCTIVE

32 Hypovolemic Shock Results from decreased preload > leads to decreased left ventricular filling and SV > leads to a fall in CO 2 subtypes 1) fluid loss: diarrhea, vomitting, osmotic diuresis, burns, heat stroke, “third spacing” 2) hemorrhagic: major trauma, upper or lower GI bleed, surgery, ruptured aneurysm, hemorrhagic pancreatitis, fractures

33 Cardiogenic Shock Develops as a result of pump failure
Mortality rate is over 50% 3 Subtypes 1) Cardiomyopathies: ischemic, infectious myocarditis, idiopathic 2) Arrhythmias: atrial or ventricular and tachy or brady 3) Mechanical: acute mitral regurgitation, critical aortic stenosis, aortic dissection, VSD

34 Distributive Shock Results from decreased SVR with a resultant abnormal distribution of blood flow Associated with a normal to increased CO Subtypes: - Sepsis - SIRS - Anaphylaxis - Neurogenic - Myxedema coma - Addisonian crisis - Drugs and toxins

35 Anaphylactic/Anaphylactoid Shock
Reaction to an exogenous stimulus Anaphylactic - IgE mediated Anaphylactoid - non-IgE mediated Massive release of mediators from mast cells and basophils Most common causes: - Drugs (beta-lactam antibiotics, ACE-I, NSAIDs) - Insects (bees, wasps) - Contrast media - Foods (seafood, nuts, milk) - Blood products

36 Anaphylactic/Anaphylactoid Shock
Onset of symptoms 5-60 minutes in majority Clinical manifestations Skin: flushing, pruritis, hives Respiratory: rhinorrhea, wheezing, stridor, dyspnea Cardiovascular: tachycardia, bradycardia, hypotension GI: nausea, vomitting, diarrhea CNS: dizziness, syncope, seizures Can have a biphasic reaction 6-12 hours later (5-20%)

37 Anaphylaxis Treatment ABC’s: Epinephrine – drug of choice:
early intubation if stridor or laryngeal edema IVF’s Epinephrine – drug of choice: ml of 1:1000 IM or SQ Antihistamines – both H1 and H2 blockers Steroids

38 Sepsis Clinical syndrome that complicates severe infection
Characterized by massive and uncontrolled release of proinflammatory mediators Leads to widespread tissue injury Estimated 750,000 cases annually Incidence increased approx 8% per year Mortality rate increases along spectrum => 7% SIRS => 16% sepsis => 20% severe sepsis => 46% septic shock (Am J Resp Crit Care Med 1996; 154:617)

39 Sepsis Definitions SIRS – systemic response to variety of insults
2 or more of following: Heart rate >90 Respiratory rate >20 or PaCO2 <32 Temperature >38 or <36 WBC >12K or <4K, or >10% band forms Sepsis – SIRS with evidence of infection Severe sepsis – sepsis asstd with organ dysfunction, hypoperfusion, or hypotension Septic shock – sepsis with hypotension despite adequate fluid resuscitation Multiple organ dysfunction (MODS) – the presence of altered organ function

40

41 Sepsis Management #1 Resuscitation
Volume infusion due to relative intravascular hypovolemia Early-goal directed – 1st 6 hours (Rivers, NEJM 2001) Goals: CVP 8-12, MAP>65, UOP>.5ml/kg/hr, SVO2>70 No advantage to colloid over crystalloid Vasopressor usage after adequate volume replacement Norepinephrine drug of choice Support of oxygenation and work of breathing Early intubation

42 Sepsis Management #2 Antibiotics Given within one hour optimal
Initial empiric broad spectrum drugs against most likely pathogens Cultures ideally prior to antibiotics

43 Sepsis Management #3 Source Control
Evaluation for focus of infection requiring intervention Abdominal abscess Infected devices Necrotic tissue Cholangitis

44 Sepsis Managment #4 Adjunctive Measures Steroids
Steroid replacement in non-responders (failure to increase cortisol >9microgr/dl after stim test) Recombinant activated protein C Has role in inflammatory and coagulation cascades Recommended in patients at high risk of death (APACHE>25, septic shock, MOF) Insulin Goal glucose control

45 Obstructive Shock Due to extracardiac impediments to CO
Most common causes: massive PE tension pneumothorax cardiac tamponade constrictive pericarditis severe pulmonary HTN with RHF

46 PA Catheter and Shock BP CO PCWP SVR
Decreased Decreased Decreased Increased Hypovolemic Decreased Increased Decr-Nl Decreased Distributive Decreased Decreased Increased Increased Cardiogenic Decreased Decreased Variable Increased Obstructive

47 Pulse Oximetry Monitoring
Pulse oximetry is a way of measuring O2 saturation by a noninvasive method which relies on the different absorption characteristics of oxyhemoglobin and deoxy hemoglobin for red (or infrared) light. The error of pulse oximetry is only around + or - 4% above the saturation of 70%. When used to measure O2 saturation below 70%, the error becomes unacceptably high.

48 Pulse Oximetry Monitoring
Pulse oximetry can yield falsely elevated O2 saturation in smokers and victims of carbon monoxide poisoning Pulse oximetry can yield falsely low values in methemoglobinemia, individuals given intravenous methylene blue or indocyanine green, in patients who are black, green or blue nail polish, and in patients who are in the presence of arc surgical lights, or fluorescent lights.

49 Upper Airway Management Problems
The complications of intubation include: Intubation of main stem bronchus Can occur even after “properly positioning” the endotracheal tube because of inadequate stabilization of the patient’s neck or excessive neck movement Neck flexion causes as much as 2 cm displacement of the tip of the endo-tracheal tube towards the carina Ideally the tube should be positioned with its tip at least 3 cm above the carina to avoid this problem If the carina is not easily seen, the tip of the endo-tracheal tube should be adjusted to be just below level of clavicles

50 Upper Airway Management Problems
Laryngeal ulceration Laryngeal ulceration occurs in almost all intubated patients to a lesser or greater degree. Damage is usually more to the posterior surfaces than the anterior surfaces. The extent of the damage is proportional to the duration of the intubation. Tracheal stenosis Sinusitis May occur in up to 42 % of patients who have a nasal tube and in up to 6% of patients who have an oral tube

51 Upper Airway Management Problems
Tracheostomy Should be considered in all patients requiring prolonged mechanical ventilation The main complication of tracheostomy is innominate artery rupture which occurs in less than 0.5% of such patients but which has a mortality of about 90%. Tracheal stenosis may also be a complication of tracheostomy and occurs particularly if a large stoma is made or excessive traction is applied.

52 Ventilator Management
The most important goals of mechanical ventilation include: Maximize pulmonary gas exchange Reduce the work of breathing Allow the lungs to heal Minimize ventilator induced lung injury

53 Ventilator Management
The following are the most important facts regarding the various types of ventilators: There are essentially two types of ventilators: Volume-cycled and pressure-cycled. Volume-cycled ventilators are designed to deliver a fixed volume (operator-selected) of air and/or oxygen using whatever (within reason) pressure needed to achieve that goal during each cycle.

54 Ventilator Management
Pressure-cycled ventilators are designed to deliver whatever volume they can using a constant pressure (operator-selected) during each cycle. Since these ventilators use constant pressure, the amount of air and/or oxygen delivered during any cycle can vary depending on various factors such as compliance of the lungs.

55 Ventilator Management
The three most common modes of mechanical ventilation include: Assist control (AC) ventilation Refers to the mode in which the ventilator recognizes when the patient is trying to breathe and immediately initiates a fully supported ventilatory cycle If patient does not make any attempt to initiate a breath, the ventilator delivers a set number of respirations per minute

56 Ventilator Management
Pressure-support ventilation (PSV) Refers to the ventilator mode in which a fixed amount of pressure is added during each breath. The airway pressure is maintained at a preset level until the patient’s inspiratory air flow falls to a preset level such as 25% of peak flow for example. The tidal volume is dependent on the patient effort, pulmonary mechanics and the amount of pressure-support. Intermittent mandatory ventilation (IMV) Refers to the mode in which the patient is allowed to initiate and complete his own breaths but nevertheless the patient is given a periodic predetermined number of mechanical ventilations with the set volume and rate

57 Ventilator Management
The initial setting of FiO2 in a patient newly intubated should be between 0.9 and 1.0 until the first set of Arterial Blood Gases (ABG) results are available and then adjusted down to maintain a pO2 of at least 60 mm Hg. The initial tidal volume setting should 6-8ml/kg based on ideal body weight

58 Ventilator Management
The inspiratory flow rate of approximately 60 L/min is adequate for most patients. However, patients with COPD may have to have a higher inspiratory flow rate (helps decrease autoPEEP) The ventilatory rate setting varies with the clinical scenario

59 Trouble-shooting Peak Airway Pressures

60 Peak and Plateau Pressures
Elevated peak and plateau pressures: Low compliance: - endobronchial (right main stem) intubation - pulmonary pathology (pna, pulm edema, hemorrhage, etc) - pneumothorax - hyperinflation: dynamic, excessive PEEP - ascites or other abdominal compartment syndrome 2) Elevated peak pressure only with normal plateau pressure: Increased system resistance: - obstruction to flow in circuit, tracheal tube - malplaced ETT - bronchospasm - aspiration/secretions

61 Weaning Used to describe process of removing patient from ventilator assistance Weaning can be short….. eg. general anesthesia, drug overdoses ….or protracted (up to a third of vent time) eg. COPD, asthma, sepsis, multiple organ failure Optimal method is controversial No great objective parameter to identify patients ready for extubation

62 Assessing Weaning Potential
Evidence for reversal of the underlying cause of respiratory failure Adequate oxygenation and pH PaO2/FiO2 ratio >200, PEEP < 5-8, FiO2 < .4 pH > 7.25 Stable hemodynamics No active cardiac ischemia No significant hypotension Ability to initiate an inspiratory effort

63 Weaning Parameters Respiratory rate Vital capacity Minute ventilation
< 30 Vital capacity > 10 mL/kg Minute ventilation Respiratory rate X tidal volume < L/min Negative inspiratory force (NIF) < -20 to –30cm H2O

64 Weaning Parameters Rapid shallow breathing index (RSBI)
Respiratory rate divided by tidal volume in milliliters If < 105 then 78-83% success rate Most accurate predictor of failure

65 Methods of Weaning SBT or T-piece trials
Trials done and duration of trial gradually increased each time Interval between trial unknown but does not appear to be difference between daily and multiple trials during day Intermittent Mandatory Ventilation (IMV) Set machine rate reduced in steps of 1-3 breaths/min Gradual reduction in amount of vent support with progressive work done by the patient Pressure Support Ventilation (PSV) Machine augments spontaneous breaths with fixed amount of positive pressure Theoretic comfort advantage to patient

66 Which is the Best? Esteban, et al. NEJM 1995
130 patients assigned randomly to 4 groups Gr 1- IMV – started at 10br/min, then decreased twice a day by 2-4 breaths: wean = 5 days Gr 2 – PSV – started at 18cmH2O, then decreased twice a day by 2-4 cm: wean = 4 days Gr 3 – Intermittent SBT – 2 or more times a day: wean = 3 days Gr 4 – Once daily SBT: wean = 3 days Conclusion: SBT groups the same and better than IMV and PSV. IMV performed the worst.

67 W eaning parameters E lectrolytes A BG – acid/base, PaO2 N utrition S ecretions N euromuscular factors – drugs O bstruction – bronchodilator treatments W akefulness

68 Upper GI Bleed Commonly presents with hematemesis and/or melena
NG lavage can confirm diagnosis and predict high risk lesion Can be negative if bleeding stopped or present beyond a closed pylorus

69 Upper GI Bleed #1 Resuscitation 2 large bore IV’s (18 gauge or larger)
Crystalloids to start Elderly with multiple comorbidities or ASCADz goal HCT close to 30

70 Upper GI Bleed #2 Reverse any coagulopathy
Check coags…if elevated INR (coumadin, liver dz, etc) then fresh frozen plasma (goal <1.5) Check CBC….if platelets <50K, then transfuse plts Check chemistries…if renal failure/uremia, then give DDAVP (causes release of Vwf…”platelet glue”)

71 Upper GI Bleed #3 Adjunctive therapies
Intravenous infusion PPI – reduces rebleeding Octreotide or somatostatin if known varices or suspected based on EtOH hx – shunts blood away from varices Look for and tap any ascites – high rate of SBP; if negative will at least need prophylactic abx ENDOSCOPY

72 DKA Present with nause, vomiting, abdominal pain, polyuria, polydipsia, wgt loss Precipitants: EtOH and drug abuse, infection, MI, dehydration, stroke, pancreatitis, trauma, noncompliance Labs: variable glucose (usually <800), hypoNa+, hyperK+, gap acidosis, serum ketones, mildly elevated amylase/lipase

73 DKA Treatment Resuscitation – IVF’s with NS initially Insulin infusion
Need some IVF’s on board first then insulin Do not turn off drip until gap resolved Potassium and phosphorous replacement Start replacing K+ when <5 Switch IVF’s to ½ NS after first 2-3L to prevent hyperchloremic acidosis Search for precipitant

74 Carbon Monoxide Poisoning
Colorless, odorless, nonirritating gas Sources: vehicle exhaust, gas heating/cooking, smoke inhalation Binds Hb with affinity 200X greater than O2 Symptoms: HA, dizziness, nausea, CP, confusion, weakness, dyspnea, ataxia, sz’s, coma Diagnosis: blood level by cooximeter Treatment: 100% O2 – reduces ½ life from 5-6 hrs to mins Hyperbaric O2 – reduces ½ life to mins

75 Chemical Warfare Agents
Agent Properties Syndrome Tx Nerve agents vaporized liquid miosis,salivation, atropine,2-pam sarin lacrimation, mm weak, soman bronchorrhea, diarrhea tabun VX Chlorine pungent yellow or bronchospasm, pulm supportive green gas edema, resp failure Sulfur mustard vaporized liquid rhinorrhea, topical supportive irritation, tracheobronch Phosgene colorless gas tracheobronch, topical supportive irritation, pulm edema

76 Overdoses and Antidotes
Acetaminophen 4 hr level and use Rumack- N-acetylcysteine Matthew nomogram, treat regardless if >7.5g’s Amphetamines Benzos Arsenic/Hg/gold/Pb BAL Benzos Flumazenil B-blocker Glucagon, CaCl, pacing Ca-blocker Ca, glucagon, pacing Coumadin Vitamin K Cyanide unexplained lactic acidosis Nitrites, thiosulfate refractory to fluids and 100% O2 in setting of smoke inhalation Digoxin Digoxin Fab

77 Overdoses and Antidotes
Ethylene glycol drunkeness, gap acidosis with Ethanol, fomepizole, osmolal gap dialysis Heparin Protamine Iron Deferoxamine INH Pyridoxine Lithium Dialysis Methanol vision complaints,gap acidosis Ethanol, fomepizole, with osmolal gap dialysis Narcotics AMS, depressed respirations, Naloxone pinpoint pupils Organophosphates SLUDE Atropine, 2-PAM Salicylates respiratory alkalosis, gap acidosis, Alkalinization, dialysis and hyperthermia Tricyclics arrhythmia, hypotension, Alkalinization, alpha anticholinergic toxicity agonist

78 Alcohol Withdrawal Minor withdrawal Withdrawal seizures
Tremulous, anxiety, diaphoresis, nausea, HA Appear within 6hrs, gone in hrs Withdrawal seizures Tonic-clonic Occur within 48 hrs Alcoholic hallucinosis Visual>auditory>tactile Appear within hrs, gone in hrs Delirium tremens Begin hrs and last 1-5 days 5% mortality Hallucinations, agitation, tachycardia, HTN, fever Treated with benzos

79 Questions?


Download ppt "Critical Care Board Review"

Similar presentations


Ads by Google